SCHEMBL16387399

SCHEMBL16387399

N#Cc1cc(Cl)c(N)c([N+](=O)[O-])c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCAM1 P19320 5/20 0.66
ALDH1A1 P00352 3/20 0.47
GRIN2D O15399 1/20 0.45
GRIN3B O60391 1/20 0.45
GRIN1 Q05586 1/20 0.45
GRIN2A Q12879 1/20 0.45
GRIN2B Q13224 1/20 0.45
GRIN2C Q14957 1/20 0.45
GRIN3A Q8TCU5 1/20 0.45
MERTK Q12866 2/20 0.44
KAT2B Q92831 1/20 0.43
CYP3A4 P08684 2/20 0.41
MTOR P42345 1/20 0.41
PLK1 P53350 1/20 0.41
MAPT P10636 2/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
CCR6 P51684 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
XDH P47989 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8409766 0.87 VCAM1 (0.66) VCAM1ALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL8409874 0.82 VCAM1 (0.59) VCAM1ALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL7886443 0.81 VCAM1 (0.58) VCAM1ALDH1A1GRIN2DGRIN3BGRIN1
Hydrochloric Acid SCHEMBL8412969 0.81 VCAM1 (0.58) VCAM1ALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL645653 0.80 VCAM1 (1.00) VCAM1ALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL25186726 0.79 VCAM1 (0.56) VCAM1ALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL1509524 0.79 VCAM1 (0.56) VCAM1ALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL15413658 0.79 VCAM1 (0.77) VCAM1ALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL6463 0.79 VCAM1 (1.00) VCAM1MERTKKAT2BMAPTMAPK1
SCHEMBL12253372 0.79 VCAM1 (1.00) VCAM1MERTKKAT2BMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9376376-B2 Substitute diphenylamine compounds use thereof as antitumor agents SINOCHEM CORPORATION (CN) 2016-06-28 US disclosed
US-20150011628-A1 SUBSTITUTE DIPHENYLAMINE COMPOUNDS USE THEREOF AS ANTITUMOR AGENTS SHENYANG RESEARCH INSTITUTE OF CHEMICAL INDUSTRY CO., LTD. (CN) 2015-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150011628-A1 SUBSTITUTE DIPHENYLAMINE COMPOUNDS USE THEREOF AS ANTITUMOR AGENTS MCL1, BRCA1, FLI1 VCAM1 4495/4885ALDH1A1 91/4885GRIN2D 4425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.